MONDAY, July 24, 2023 (HealthDay News) — Here’s another reason to get your kids up and moving: Excessive TV watching in childhood leads to a higher risk of metabolic syndrome at age 45, a new long-term study finds. “What’s really important about this is that even if these sedentary kidsContinue Reading
MONDAY, July 24, 2023 (HealthDay News) — Restricting eating to certain times — a regimen known as intermittent fasting — may be the best way to help people with type 2 diabetes lose weight. Researchers found that people with type 2 diabetes who ate only between noon and 8 p.m.Continue Reading
MONDAY, July 17, 2023 (HealthDay News) — People with type 2 diabetes could soon have access to convenient once-a-week insulin shots that could replace the daily injections now required. A once-weekly insulin formulation called icodec performed just as well as daily doses of the insulin degludec, phase 3 clinical trialContinue Reading
THURSDAY, July 13, 2023 (HealthDay News) — A bunch of healthy fruits and vegetables could be just what the doctor ordered. Nonprofit groups and public health agencies have experimented with the idea of a produce prescription over the years. Now, a new study simulates what would happen if patients withContinue Reading
WEDNESDAY, July 12, 2023 (HealthDay News) — A multinational team of engineers and surgeons has developed a bionic hand with a high level of function in every finger — a significant advance for amputees. The team, from the United States, Sweden, Australia and Italy, developed a way to reconfigure whatContinue Reading
THURSDAY, July 6, 2023 (HealthDay News) — Loneliness might be a true heartbreaker for people with diabetes — raising their odds of a heart attack even more than unhealthy lifestyle habits do. That’s according to a new study of over 18,000 adults with the blood sugar disease. Researchers found thatContinue Reading
WEDNESDAY, July 5, 2023 (HealthDay News) — You have been diagnosed with type 2 diabetes. What are your medication options? That depends on what type of diabetes you have and what risk factors you carry. In type 2 diabetes, the body becomes resistant to the insulin and the pancreas hasContinue Reading
MONDAY, July 3, 2023 (HealthDay News) — The trendy weight-loss drug Ozempic could be dangerous for a patient undergoing anesthesia for an operation, according to a new warning from the American Society of Anesthesiologists. Semaglutide (Ozempic, Wegovy) and other drugs of their class known as GLP-1 receptor agonists cause digestionContinue Reading
THURSDAY, June 29, 2023 (HealthDay News) — Pairing exercise with a 10% weight loss can make a major health improvement in people living with obesity and prediabetes, a new study says. Building in regular exercise more than doubled sensitivity to insulin compared to just weight loss alone. This has theContinue Reading
WEDNESDAY, June 28, 2023 (HealthDay News) — Having a couple of drinks a day won’t protect you from obesity or diabetes, a new study suggests. Everybody knows that heavy drinking isn’t good for your health, but whether moderate alcohol consumption is protective or harmful is still open for debate, researchersContinue Reading
TUESDAY, June 27, 2023 (HealthDay News) — Gastric bypass surgery is a potential long-term cure for type 2 diabetes, especially if the procedure is performed before the disease progresses, a new study argues. Among a large group of obese people with type 2 diabetes, about half achieved remission for anContinue Reading
MONDAY, June 26, 2023 (HealthDay News) — After drugmaker Novo Nordisk tweaked its diabetes drug Ozempic into Wegovy — a formulation expressly designed to help users shed pounds — sales of both drugs skyrocketed. Other pharmaceutical giants took notice, and over the past weekend the results of multiple clinical trialsContinue Reading
FRIDAY, June 23, 2023 (HealthDay News) — Diabetes is skyrocketing, with more than 500 million people of all ages living with the disease today and the number of cases worldwide projected to hit 1.3 billion in the next 30 years. “The rapid rate at which diabetes is growing is notContinue Reading
WEDNESDAY, June 21, 2023 (HealthDay News) — The U.S. Food and Drug Administration on Tuesday approved two drugs that have been used in adults with type 2 diabetes for years for use in children aged 10 and up. The approvals of Jardiance (empagliflozin) and Synjardy (empagliflozin and metformin hydrochloride) provideContinue Reading